Connecting to LinkedIn...

W1siziisijiwmtuvmdqvmtuvmdgvntqvmzgvnzi1l01ptlrbu0hfqkxpr19vtljftkrfukvex0lnqudfx3jlc2l6zwrfyw5kx3jlbmrlcmvklmpwzyjdlfsiccisinrodw1iiiwimtkymhgxmjuwiyjdxq

Blog

NeuClone signs biosimilar deal with Serum Institute

7/07/2014 by

W1siziisijiwmtqvmtavmjgvmtuvmzqvmtqvodkzl2zpbguixsxbinailcj0ahvtyiisijywmhg0mdbcdtawm2uixv0

Sydney-based biotech NeuClone has signed a major licensing agreement and joint development partnership with The Serum Institute of India covering the manufacturing of 10 biosimilar drugs.

Under the agreement, NeuClone will use its NeuMAX cell line development platform to manufacture and supply 10 biosimilar monoclonal antibody drugs. The Serum Institute, the world’s largest vaccine producer, will provide its biologics manufacturing capability.

The drugs will have targets including cancer and autoimmune disorders, and each will address markets worth hundreds of millions to billions of dollars, the companies said.

As part of the partnership, NeuClone will retain the licence to the biosimilars for the markets of the US, Europe, Canada, Australia, Taiwan, Japan and South Korea. The company said it will seek partnerships with large pharmaceutical and generics companies in these markets.

The Serum Institute will meanwhile receive an exclusive worldwide licence for marketing and sales of the drug in the rest of the world. The institute plans to use the collaboration to deliver biosimilar versions of expensive drugs to markets of patients that have been unable to afford the real thing.

This article has been extracted from http://lifescientist.com.au, please click on this link to read the article in full http://lifescientist.com.au/content/biotechnology/news/neuclone-signs-biosimilar-deal-with-serum-institute-972901099

Montash is a multi-award winning, global IT recruitment firm. Specialising in permanent and contract positions across mid-senior appointments which cover a wide range of industry sectors and IT functions, including:

ERP, BI & Data, Information Security, IT Architecture & Strategy, Scientific Technologies, Demand IT and Business Engagement, Digital and E-commerce, Infrastructure and Service Delivery, Project and Programme Delivery.

With offices based in London, Montash has completed assignments in over 30 countries and has appointed technical professionals from board level to senior and mid-management in permanent and contract roles.

comments powered by Disqus

Social Stream

Latest News

W1siziisijiwmtcvmdkvmtgvmtavmtivndyvodeyl1dvbwvuigluihrly2ggkdiplmpwzyjdlfsiccisinrodw1iiiwimzgwedewmcmixv0

Tech is for girls... and always has been!

2017-09-18 10:00:00 +0100

Today, it's hard to deny that the IT and tech industry is a male-dominated field. Women earn only 28%[1] of computer science degrees, while the quit rate for women in the high tech industry is 41%[2], twice as high as it is for men. These two statistics would suggest that perhaps women aren't just discouraged from entering the tech field, but may find it a challenging environment to work in both in terms of treatment and pay. Facebook chief operating of...

W1siziisijiwmtcvmdkvmdgvmtevmtuvmzqvmtgwl0hpcmluzybnaxn0ywtlcy5qcgcixsxbinailcj0ahvtyiisijm4mhgxmdajil1d

Common Hiring Mistakes for SAP Consultants

2017-09-08 12:00:00 +0100

Choosing the wrong consultant can lead a project down a ruinous path. Deadlines get missed, quality of work decreases and money is wasted. When you're putting together a new SAP project, getting the right talent is paramount. We discussed hiring mistakes with our Senior Business Manager, Adam Blaney and asked him the question of how to minimise risk in hiring SAP Consultants. “Hiring any form of technology based consultant is difficult. The hardest part...